These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28993327)

  • 1.
    Goldstein EJC; Citron DM; Tyrrell KL; Leoncio ES
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of ceftolozane-tazobactam against a broad spectrum of recent clinical anaerobic isolates.
    Snydman DR; McDermott LA; Jacobus NV
    Antimicrob Agents Chemother; 2014; 58(2):1218-23. PubMed ID: 24277025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of anaerobic bacteria in Sweden in 1983.
    Nord CE; Olsson-Liljequist B
    Scand J Infect Dis Suppl; 1984; 43():44-9. PubMed ID: 6100139
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Goldstein EJC; Citron DM; Tyrrell KL; Leoncio ES
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
    Nord CE; Olsson-Liljequist B
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Stapert L; Wolfe C; Shinabarger D; Marra A; Pillar C
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria.
    Tran CM; Tanaka K; Yamagishi Y; Goto T; Mikamo H; Watanabe K
    Antimicrob Agents Chemother; 2011 May; 55(5):2398-402. PubMed ID: 21343447
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Goldstein EJC; Merriam CV; Citron DM
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32631819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of 10 antibiotics including pristinamycin and its two components (RP 12536 and 27404) against strict anaerobes].
    Dubreuil L; Houcke I; Singer E
    Pathol Biol (Paris); 1998 Feb; 46(2):147-52. PubMed ID: 9769928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
    Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
    Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 May; 57(5):2401-4. PubMed ID: 23459482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of the in vitro activity of gemifloxacin against gram-positive and gram-negative anaerobic pathogens.
    Goldstein EJ
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():55-65. PubMed ID: 10824034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activities of SMT19969, a new antimicrobial agent, against Clostridium difficile and 350 gram-positive and gram-negative aerobic and anaerobic intestinal flora isolates.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4872-6. PubMed ID: 23877700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigations into the occurrence and the antibiotic susceptibility of gram negative anaerobes of the genera Bacteroides, Prevotella, Porphyromonas and Fusobacterium in specimens obtained from diseased animals].
    Even H; Rohde J; Verspohl J; Ryll M; Amtsberg G
    Berl Munch Tierarztl Wochenschr; 1998 Oct; 111(10):379-86. PubMed ID: 9818460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.
    Chow AW; Patten V; Guze LB
    J Infect Dis; 1975 Feb; 131(2):182-5. PubMed ID: 163867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of ceftaroline, ceftaroline-avibactam, and other antimicrobial agents against aerobic and anaerobic bacteria cultured from infected diabetic foot wounds.
    Goldstein EJ; Citron DM; Merriam CV; Tyrrell KL
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):347-51. PubMed ID: 23623385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antibiotic susceptibility of Bacteroides, Prevotella and Fusobacterium species isolated from patients of the N. N. Blokhin Cancer Research Center, Moscow, Russia.
    Shilnikova II; Dmitrieva NV
    Anaerobe; 2015 Feb; 31():15-8. PubMed ID: 25157873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of cefpodoxime against anaerobes other than Bacteroides fragilis.
    Werner H; Heizmann WR; Höflsauer M
    Infection; 1991; 19(5):377-9. PubMed ID: 1800380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.